OBJECTIVE: To examine healthcare resource utilization for acute respiratory illness in Latino infants compared with other racial/ethnic groups. STUDY DESIGN: We studied 674 term-born, previously healthy infants brought in for an unscheduled healthcare visit for an acute respiratory illness. The predictor variable was infant race/ethnicity, and the primary outcome was healthcare resource utilization, adjusted for age and disease severity. RESULTS: The cohort was 14% Latino, 52% white, 22% African American, and 12% other race/ethnicity. More than one-third (37%) of the mothers of Latino infants were Spanish-speaking. The bronchiolitis severity score was higher (indicating more severe disease) in white infants (median, 6.0; IQR, 3.0-9.0 on a scale of 0-12) compared with Latino (median, 3.0; IQR, 1.0-6.0) and African American (median, 3.5; IQR, 1.0-6.0) infants (P < .001 for the comparison of all groups). Disease severity was similar in Latino and African American infants (P = .96). Latino infants were the most likely to receive antibiotics (58%, compared with 47% of whites and 34% of African Americans; P = .005) and to have body fluid cultures drawn. Latino infants also were more likely than African American infants to undergo chest radiography and respiratory virus rapid antigen testing (P ≤ .01). Latino infants from Spanish-speaking families had a higher rate of respiratory syncytial virus testing compared with those from English-speaking families (76% vs 51%; P = .016). CONCLUSION: Providers caring for Latino infants with acute respiratory illness ordered more antibiotics and diagnostic testing for this group, particularly compared with African Americans, even though the 2 groups had similar disease severity and socioeconomic disparities. Language barrier may be a possible explanation for these differences.
OBJECTIVE: To examine healthcare resource utilization for acute respiratory illness in Latino infants compared with other racial/ethnic groups. STUDY DESIGN: We studied 674 term-born, previously healthy infants brought in for an unscheduled healthcare visit for an acute respiratory illness. The predictor variable was infant race/ethnicity, and the primary outcome was healthcare resource utilization, adjusted for age and disease severity. RESULTS: The cohort was 14% Latino, 52% white, 22% African American, and 12% other race/ethnicity. More than one-third (37%) of the mothers of Latino infants were Spanish-speaking. The bronchiolitis severity score was higher (indicating more severe disease) in white infants (median, 6.0; IQR, 3.0-9.0 on a scale of 0-12) compared with Latino (median, 3.0; IQR, 1.0-6.0) and African American (median, 3.5; IQR, 1.0-6.0) infants (P < .001 for the comparison of all groups). Disease severity was similar in Latino and African American infants (P = .96). Latino infants were the most likely to receive antibiotics (58%, compared with 47% of whites and 34% of African Americans; P = .005) and to have body fluid cultures drawn. Latino infants also were more likely than African American infants to undergo chest radiography and respiratory virus rapid antigen testing (P ≤ .01). Latino infants from Spanish-speaking families had a higher rate of respiratory syncytial virus testing compared with those from English-speaking families (76% vs 51%; P = .016). CONCLUSION: Providers caring for Latino infants with acute respiratory illness ordered more antibiotics and diagnostic testing for this group, particularly compared with African Americans, even though the 2 groups had similar disease severity and socioeconomic disparities. Language barrier may be a possible explanation for these differences.
Authors: Laura P Shone; Andrew W Dick; Cindy Brach; Kim S Kimminau; Barbara J LaClair; Elizabeth A Shenkman; Jana F Col; Virginia A Schaffer; Frank Mulvihill; Peter G Szilagyi; Jonathan D Klein; Karen VanLandeghem; Janet Bronstein Journal: Pediatrics Date: 2003-12 Impact factor: 7.124
Authors: Gabrielle B McCallum; Peter S Morris; Clare C Wilson; Lesley A Versteegh; Linda M Ward; Mark D Chatfield; Anne B Chang Journal: Pediatr Pulmonol Date: 2012-09-04
Authors: Juan P Wisnivesky; Meyer Kattan; David Evans; Howard Leventhal; Tamara J Musumeci-Szabó; Thomas McGinn; Ethan A Halm Journal: Med Care Date: 2009-02 Impact factor: 2.983
Authors: Jessica E McDade; Aleksandra E Olszewski; Pingping Qu; Jessica Ramos; Shaquita Bell; Alicia Adiele; Joan Roberts; Tumaini R Coker Journal: Front Pediatr Date: 2022-07-05 Impact factor: 3.569
Authors: Aubree C Honcoop; Patricia Poitevien; Ellen Kerns; Brian Alverson; Russell J McCulloh Journal: Acad Emerg Med Date: 2021-06-11 Impact factor: 5.221
Authors: Jane W Njeru; Jennifer L St Sauver; Debra J Jacobson; Jon O Ebbert; Paul Y Takahashi; Chun Fan; Mark L Wieland Journal: BMC Health Serv Res Date: 2015-05-29 Impact factor: 2.655
Authors: Jane W Njeru; Swathi Damodaran; Frederick North; Debra J Jacobson; Patrick M Wilson; Jennifer L St Sauver; Carmen Radecki Breitkopf; Mark L Wieland Journal: BMC Health Serv Res Date: 2017-11-09 Impact factor: 2.655
Authors: Barbara Rath; Tim Conrad; Puja Myles; Maren Alchikh; Xiaolin Ma; Christian Hoppe; Franziska Tief; Xi Chen; Patrick Obermeier; Bron Kisler; Brunhilde Schweiger Journal: Expert Rev Anti Infect Ther Date: 2017-05-12 Impact factor: 5.091